Andrea Spallarossa

25PUBLICATIONS
33CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersClinical pharmacology and therapeuticsMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 23, 2026
Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors.

|Oct 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

Matteo Lusardi, Federica Rapetti, Andrea Spallarossa

|Jul 12, 2025
Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

Chiara Brullo, Barbara Marengo, Cinzia Domenicotti

|Aug 10, 2024
PDE4D: A Multipurpose Pharmacological Target.

Matteo Lusardi, Federica Rapetti, Andrea Spallarossa

|Jun 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti

|May 25, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.

Federica Rapetti, Andrea Spallarossa, Eleonora Russo

Pageof 5

Frequent Collaborators

17 joint publications

Chiara Brullo

12 joint publications

Matteo Lusardi

9 joint publications

Bruno Tasso

6 joint publications

Carla Villa